Expression of Myeloid Antigen in Neoplastic Plasma Cells Is Related to Adverse Prognosis in Patients with Multiple Myeloma
Figure 2
Kaplan-Meier analysis of (a) progression free survival (PFS) and (b) overall survival (OS) in groups of patients positive and negative for CD33 and CD13. CD33 expression demonstrates a potential prognostic impact and was associated with lower OS (). Patients with CD13 associated with significantly shorter PFS times (), not only lower OS ().